Live Feed

TEL AVIV, Israel, April 28, 2026 (GLOBE NEWSWIRE) -- LightSolver, a pioneer in laser-based computing for physics-intensive workloads, today announced a strategic financial partnership with Boeing (NYSE:BA) to advance laser-based computing acceleration for complex engineering simulations. The collaboration focuses on improving the performance, scalability, and energy efficiency of critical physics-based modeling that underpins modern engineering design and lifecycle management.  Through this engagement, Boeing is funding the continued development and optimization of LightSolver's Laser Processing Unit™, or LPU, with an emphasis on adapting the technology to real-world engineering requireme

HERZLIYA, Israel, April 28, 2026 (GLOBE NEWSWIRE) -- Nayax Ltd. (NASDAQ:NYAX, TASE: NYAX)), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced that it will release its earnings for the first quarter of 2026 on Tuesday, May 12, 2026, before U.S. markets open. Nayax will hold two calls, one in English and one in Hebrew. Nayax CEO and Chairman, Yair Nechmad, will speak alongside Nayax's Chief Financial Officer, Sagit Manor, and Chief Strategy Officer, Aaron Greenberg. Conference Calls: The conference call in English will be held at: 8:30 a.m. Eastern Time / 3:30 p.m. Israel Time

SHENZHEN, China, April 29, 2026 (GLOBE NEWSWIRE) -- Xunlei Limited ("Xunlei" or the "Company") (NASDAQ:XNET), a leading technology company providing distributed cloud services in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission (the "SEC") on April 28, 2026. The annual report can be accessed on the Company's investor relations website at http://ir.xunlei.com or the SEC's website at www.sec.gov. About Xunlei Founded in 2003, Xunlei Limited (NASDAQ:XNET) is a leading technology company providing distributed cloud services in China. Xunlei provides a wide range of products and service

4 - Traws Pharma, Inc. (0001130598) (Issuer)

SEOUL, South Korea, April 28, 2026 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced that its 27-inch 540/720Hz Dynamic Frequency & Resolution (DFR) Gaming OLED panel has been awarded "Display of the Year" by the Society for Information Display (SID), receiving high acclaim for redefining the gaming display paradigm and accelerating market differentiation. The "Display of the Year" award is SID's most prestigious distinction, presented to the most groundbreaking display product launched during the previous year that is expected to lead

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L for the treatment of chronic low back pain (CLBP) associated with degenerative disc disease has achieved its patient recruitment target. This marks a significant milestone in Mesoblast's plans for commercialization of rexlemestrocel-L, its proprietary allogeneic stromal cell therapy targeting inflammatory processes underlying disc degeneration. The placebo-controlled study (MSB-DR004) will follow at least 300 patients randomized to a single intra-

ROCHESTER, NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (NASDAQ:OPTX) ("Syntec Optics", "Syntec", or the "Company"), a leading provider of technology to defense tech and other vibrant end-markets, today announced the pricing of an underwritten public offering of 2,857,142 shares of its common stock at a public offering price of $7.00 per share. H.C. Wainwright & Co. is acting as sole book-running manager for the offering. In addition, the Company granted the underwriter a 30-day option to purchase up to 428,571 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to clos

Advancing growth and delivering reliable energy Performance highlights Sangomar, Shenzi, North West Shelf Project and Pluto LNG all delivered outstanding reliability at or above 99%. Achieved an average realised quarterly price of $63/boe, up 11% from Q4 2025 reflecting benefits from market prices. Delivered quarterly production volumes of 45.2 MMboe (502 Mboe/d), down 8% from Q4 2025 due to seasonal weather events. Project highlights The Scarborough Energy Project was 96% complete and remains on budget and on track for first LNG cargo in Q4 2026. The Scarborough Floating Production Unit (FPU) completed hook-up and commenced topside commissioning following its arrival in

BOGOTA, Colombia, April 28, 2026 /PRNewswire/ -- Ecopetrol S.A ((BVC: ECOPETROL, NYSE:EC) hereby announces that on Tuesday, May 12, 2026, it will release its financial and operational results for the first quarter of 2026, after market closes. On Wednesday, May 13, 2026, the company's management will hold a virtual earnings conference call, with simultaneous webcasts in Spanish and English, at the following times:Conference Call 09:00 a.m. Colombia Time10:00 a.m. New York TimeTo participate in the conference call, please use the following link and select the preferred language f

Aggregate offering size of $5 billion Pershing Square USA, Ltd. ("PSUS"), an investment company managed by Pershing Square Capital Management, L.P. ("PSCM"), and Pershing Square Inc. ("PSI"), the parent company of PSCM, today announced the pricing of the combined initial public offering (the "PSUS IPO") of the common shares of beneficial interest of PSUS (the "PSUS Shares") and the initial public offering (the "PSI IPO", and together with the PSUS IPO, the "Combined IPO") of the common stock of PSI (the "PSI Shares"). The PSUS Shares and the PSI Shares are expected to begin trading on the New York Stock Exchange (NYSE) on April 29, 2026, under the symbol "PSUS" for the PSUS Shares and u

MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (NASDAQ:ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications, today announced the pricing of its upsized underwritten public offering of 9,660,000 shares of its common stock at a price to the public of $72.50 per share. The gross proceeds to Oruka from this offering are expected to be approximately $700.4 million, before deducting underwriting discounts and commissions and other offering expenses and excluding any exercise of the underwriters' option to purchase additional shares. In additio

4 - ABBOTT LABORATORIES (0000001800) (Issuer)

RAPID CITY, S.D., April 28, 2026 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE:BKH) today announced that its board of directors declared a quarterly dividend on the common stock at a meeting held April 28, 2026. Common shareholders of record at the close of business on May 15, 2026, will receive $0.703 per share, payable June 1, 2026. The company also confirms that it will release its 2026 first-quarter earnings after the market closes Wednesday, May 6, 2026, and will host a live conference call and webcast at 11 a.m. EDT on Thursday, May 7, 2026, to discuss the company's financial results. To participate by phone and ask a question during the live broadcast, participants can access the ev

Trusted, intuitive AI enhances design workflows, making it easier to move from creative concepts to 3D modelsWESTMINSTER, Colo., April 28, 2026 /PRNewswire/ -- Trimble (NASDAQ:TRMB) today announced a specialized integration with Claude, the large language model and AI assistant from Anthropic, that makes it easier for Trimble® SketchUp® software users to create 3D models directly from conversational text or speech prompts. The powerful new capabilities are enabled by a SketchUp Connector model context protocol (MCP) service that allows Claude to interact directly with SketchUp (

TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Borealis Foods Inc. (NASDAQ:BRLS) ("Borealis" or the "Company"), a food science company focused on nutritious, convenient food solutions, today announced that its subsidiaries entered into a $17.0 million term loan facility with Oxus Capital PTE Ltd. ("Oxus"), a significant shareholder of the Company, to repay in full the Company's existing obligations to Frontwell Capital Partners Inc. ("Frontwell"), improve near-term financial flexibility, and support operations. The transaction reflects confidence in Borealis' operating platform and market opportunity. The Company continues to see demand for its flagship products, including Chef Woo, Ramen Ex

FORT WORTH, Texas, April 28, 2026 (GLOBE NEWSWIRE) -- FirstCash Holdings, Inc. ("FirstCash" or the "Company") (NASDAQ:FCFS) today announced that the Company's wholly-owned subsidiary, FirstCash, Inc. (the "Issuer"), has upsized and priced its previously announced private offering of $750,000,000 in aggregate principal amount of senior notes due 2034 (the "Notes"), representing an increase of $150,000,000 in aggregate principal amount from the previously announced proposed offering size. The Notes will pay interest semi-annually at a rate of 6.125% per annum payable on May 1 and November 1 of each year, beginning on November 1, 2026. The Notes will be unsecured senior obligations of the Is

WASHINGTON, April 28, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced the publication of the original research article titled "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in New England Journal of Medicine (NEJM) Evidence1. The findings of this pivotal phase III study are included in the Biologics License Application (BLA) for imsidolimab for the treatment of Generalized Pustular Psoriasis (GPP), submitted to the U.S. Food and Drug Administration (FDA) with a target action date of December 12, 2026.ReferencesSmiesz

/C O R R E C T I O N – Elanco Animal Health/ In the news release, Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock, issued 27-Apr-2026 by Elanco Animal Health over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock Action Prepares Veterinarians and Livestock Prod

EPS Increases 6% to $0.90 from $0.85 for the Comparable Quarter One Year AgoQuarterly Return on Average Assets of 1.43%Quarterly Return on Average Equity of 10.72%Quarterly Net Interest Margin of 3.81% HOQUIAM, Wash., April 28, 2026 (GLOBE NEWSWIRE) -- Timberland Bancorp, Inc. (NASDAQ:TSBK) ("Timberland" or "the Company"), the holding company for Timberland Bank (the "Bank"), today reported net income of $7.13 million, or $0.90 per diluted common share for the quarter ended March 31, 2026. This compares to net income of $6.76 million, or $0.85 per diluted common share for the comparable quarter one year ago, and $8.22 million, or $1.04 per diluted common share, for the preceding quarter.

CALGARY, AB, April 28, 2026 /CNW/ - The Board of Directors of Canadian Pacific Kansas City Limited (TSX:CP) (NYSE:CP) (CPKC) today declared a quarterly dividend of $0.268 per share on the outstanding Common Shares, an increase of 17.5 percent to the previous dividend of $0.228 per share."We are pleased to announce an increase to our dividend as part of our ongoing commitment to returning cash to our shareholders," said Keith Creel, CPKC President and Chief Executive Officer. "In the three years since our historic combination, CPKC has successfully demonstrated the power of our unique network, the resiliency of our operating model, and our dedication to creating value for our shareholders."Th